Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
Mitochondrial DNA sequence variation in multiple sclerosis.
Urinary tract infections in multiple sclerosis.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Purkinje cell dysfunction and delayed death in plasma membrane calcium ATPase 2-heterozygous mice.
The progress of cognitive decline in newly diagnosed MS patients.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
Lack of association between CD226 genetic variants and inflammatory demyelinating diseases in Korean population.
Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.
Purines in neurodegeneration and neuroregeneration.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Autoimmune diseases and reproductive aging.
Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
Vitamin D and the central nervous system.
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β

Pages